152 related articles for article (PubMed ID: 28056409)
1. Efficacy of metformin in human single hair fibre by ATR-FTIR spectroscopy coupled with statistical analysis.
Sundaramoorthi K; Sethu G; Ethirajulu S; Raja Marthandam P
J Pharm Biomed Anal; 2017 Mar; 136():10-13. PubMed ID: 28056409
[TBL] [Abstract][Full Text] [Related]
2. Mechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal RS; Krssak M; Dufour S; Laurent D; Lebon V; Chandramouli V; Inzucchi SE; Schumann WC; Petersen KF; Landau BR; Shulman GI
Diabetes; 2000 Dec; 49(12):2063-9. PubMed ID: 11118008
[TBL] [Abstract][Full Text] [Related]
3. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Effects of Metformin in Humans.
Adeva-Andany MM; Rañal-Muíño E; Fernández-Fernández C; Pazos-García C; Vila-Altesor M
Curr Diabetes Rev; 2019; 15(4):328-339. PubMed ID: 30306875
[TBL] [Abstract][Full Text] [Related]
5. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
[TBL] [Abstract][Full Text] [Related]
6. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
[TBL] [Abstract][Full Text] [Related]
7. Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome.
Kraemer de Aguiar LG; Laflor CM; Bahia L; Villela NR; Wiernsperger N; Bottino DA; Bouskela E
Diabet Med; 2007 Mar; 24(3):272-9. PubMed ID: 17263761
[TBL] [Abstract][Full Text] [Related]
8. The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea-treated type 2 diabetic patients with sub-optimal metabolic control.
Mughal MA; Jan M; Maheri WM; Memon MY; Ali M
J Pak Med Assoc; 2000 Nov; 50(11):381-6. PubMed ID: 11126815
[TBL] [Abstract][Full Text] [Related]
9. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of metformin hydrochloride in Wistar rats by FTIR-ATR spectroscopy: A convenient tool in the clinical study of diabetes.
Ramalingam P; Reddy YP; Kumar KV; Chandu BR; Rajendran K
J Nat Sci Biol Med; 2014 Jul; 5(2):288-92. PubMed ID: 25097400
[TBL] [Abstract][Full Text] [Related]
11. Evaluation, efficacy and tolerability of GlucoNovax tablet in type 2 diabetic patients.
Ali Z; Daniyal M; S I I; Usmanghani K; Naveed S
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1443-9. PubMed ID: 27592478
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cyclea peltata Lam. roots aqueous extract on glucose levels, lipid profile, insulin, TNF-alpha and skeletal muscle glycogen in type 2 diabetic rats.
Kirana H; Srinivasan BP
Indian J Exp Biol; 2010 May; 48(5):499-502. PubMed ID: 20795368
[TBL] [Abstract][Full Text] [Related]
13. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A
Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
[TBL] [Abstract][Full Text] [Related]
14. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
15. Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy.
El-Sayed MI
J Ethnopharmacol; 2011 Sep; 137(1):643-51. PubMed ID: 21718775
[TBL] [Abstract][Full Text] [Related]
16. Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal.
Mathieu-Costello O; Kong A; Ciaraldi TP; Cui L; Ju Y; Chu N; Kim D; Mudaliar S; Henry RR
Metabolism; 2003 May; 52(5):540-6. PubMed ID: 12759881
[TBL] [Abstract][Full Text] [Related]
17. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
Strowig SM; Raskin P
Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone plus a sulphonylurea or metformin is associated with increased lipoprotein particle size in patients with type 2 diabetes.
Perez A; Khan M; Johnson T; Karunaratne M
Diab Vasc Dis Res; 2004 May; 1(1):44-50. PubMed ID: 16305056
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.
Betteridge DJ; Vergès B
Diabetologia; 2005 Dec; 48(12):2477-81. PubMed ID: 16283239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
